返回
CRISPR-Cas-mediated diagnostics
DOI:10.1016/j.tibtech.2022.04.006.png)
摘要
En 中文
An ideal molecular diagnostic method should be sensitive, specific, low cost, rapid, portable, and easy to operate. Traditional nucleic acid detection methods based mainly on PCR technology have not only high sensitivity and specificity, but also some limitations, such as the need for expensive equipment and skilled technicians, being both time and labor intensive, and difficult to implement in some regions. However, with the continuous development of CRISPR-Cas technology and its application in molecular diagnosis, new approaches have been used for the construction of molecular diagnostic systems. In this review, we discuss recent advances in CRISPR-based molecular diagnostic technologies and highlight the revolution they bring to the field of molecular diagnostics.
Keyword:
NUCLEIC-ACID DETECTION
EPSTEIN-BARR-VIRUS
REAL-TIME PCR
IMMUNE-SYSTEM
RNA
DNA
AMPLIFICATION
PLATFORM
ASSAY
UNIVERSAL
期刊
IF:
14.9
论文数:
3.8K
被引数:
2.0W
机构
引用论文
CRISPR-based peptide library display and programmable microarray self-assembly for rapid quantitative protein binding assays
MOLECULAR CELL
IF16.6
Programmed genome editing by a miniature CRISPR-Cas12f nuclease通过微型CRISPR-Cas12f核酸酶进行程序化基因组编辑
NATURE CHEMICAL BIOLOGY
IF13.7
Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2简化的SARS-CoV-2失活、扩增和Cas13-based检测
NATURE COMMUNICATIONS
IF15.7
CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNACRISPR-Cas12a对单链DNA具有顺式和反式切割活性
CELL RESEARCH
IF25.9
Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients
BMC MICROBIOLOGY
IF4.2

